Full Professor(heuristic)

Cancer Immunotherapy and Biomarkers · Oncology

Compare more Oncology professors.

h-index42
i10-index88
Publications270
Citations13,014

Grants

No NSF/NIH grants on record.

Recent Public Signals

  1. New paper: Technical evaluation of commercially available homologous recombination deficiency assays using MyChoice CDx as reference in ovarian cancer (Gynecologic Oncology)2026-06-25
  2. New preprint: Supplementary Figure S2 from Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma2024-12-02

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-08-25

Data may not be current

Find elsewhere

ORCID: 0000-0002-9978-0339

Professor Insights

Career Trajectory